| Application no. and date | 14773638.3 (espacenet) (Federated) (European Patent Register), 20140327 | | Patent/reg. no. and date | DK/EP 2979700, 20180926 | | Publication date | 20160203 | | Priority no. and date | JP 2013066074, 20130327 | | EP pub. no. and date |
EP 2979700 20160203 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27, Kandanishiki-cho
Chiyoda-ku, Tokyo 101-8444, JP | | Applicant ref. no. | V149197 | | Inventor | OKABE, Hiroyuki, c/o Taiho Pharmaceutical Co., Ltd.
3
Okubo
Tsukuba-shi
Ibaraki 300-2611, JP | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4745 (2006.01) , A61K 31/506 (2006.01) , A61K 31/7072 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) | | Title | ANTITUMORMIDDEL, DER INDBEFATTER EN LAV IRINOTECANHYDROCHLORIDHYDRAT | | Int. application no. | JP2014058733 | | Int. publication no. | WO2014157444 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
